Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants
Marina Macchini, Federico Centonze, Umberto Peretti, Giulia Orsi, Anna Maria Militello, Maria Maddalena Valente, Stefano Cascinu, Michele Reni
Topics & Concepts
PALB2MedicineGermlineSynthetic lethalityDNA repairGermline mutationPARP inhibitorCancer researchPopulationHomologous recombinationPancreatic cancerDNA mismatch repairCancerGenePoly ADP ribose polymeraseMutationGeneticsBiologyInternal medicineEnvironmental healthPolymerasePancreatic and Hepatic Oncology ResearchPARP inhibition in cancer therapyCancer Genomics and Diagnostics